Plasma Dipeptidyl Peptidase-4 Activity, a Novel Biomarker or Even a Possible Therapeutic Target for Depression in Type 2 Diabetic Patients: Results from a Cross-Sectional Study in China

Psychother Psychosom. 2017;86(4):254-256. doi: 10.1159/000455928. Epub 2017 Jun 24.

Authors

Tianpeng Zheng¹, Linyuan Qin, Bo Chen, Xueping Hu, Xiaoxi Zhang, Yihong Liu, Hongbo Liu, Shenghua Qin, Gang Li, Qinghua Li

Affiliation

¹ Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.

PMID: 28647741
DOI: 10.1159/000455928

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Biomarkers / blood
China
Cross-Sectional Studies
Depression / blood*
Depression / complications
Depression / enzymology
Depression / therapy*
Diabetes Mellitus, Type 2 / complications*
Dipeptidyl Peptidase 4 / blood*
Humans
Middle Aged
Risk Factors

Substances

Biomarkers
Dipeptidyl Peptidase 4